Molecular Testing for GI Pathogens: Cost-Effectiveness, Clinical Impact and Lab Implementation
Diarrheal infections represent a significant healthcare burden worldwide. Clinically, treatment varies depending on the identity of the stool pathogen, so rapid and accurate identification of pathogenic bacteria and viruses from a stool specimen is critical. Conventional diagnostics weigh down laboratories with extensive hands-on time, low sensitivity, and long turnaround times, which fall short of meeting the time-sensitive needs of clinicians to inform treatment decisions. Multiplexed molecular methods are very well-suited to address this diagnostic need. This complementary webinar will provide an in-depth analysis of the clinical and economic value of molecular testing for GI pathogens and describe the impact implementation of these tests can have on laboratory efficiency.